Source disclosure: February 19, 2026
Carna Biosciences,Inc. [4572.T]
TOKYO, Feb 19 (Pulse News Wire) – Carna Biosciences,inc. (4572.T) announced decisions made during its board meeting held on February 19 regarding candidates for the upcoming 23rd annual shareholders' general meeting scheduled for March 25.
The company confirmed the reappointment of several directors, including Yoshino Kojiro, Sawama Aki, and Yamamoto Emi. Additionally, Arimura Akinori was also reappointed while Okanoue Kunihiro joins as a new director. Regarding the audit committee, Ariya Atsuo and Matsui Takao were reappointed, while Suzuki Kaoru and Terada Katsumoto join as new members. However, Ogasawara Tsuguo, currently serving as an external auditor, will retire upon the conclusion of the shareholders' meeting on March 25 due to term expiration.
In addition, detailed profiles of the newly appointed directors and audit committee members were released. Okanoue Kunihiro, joining as a new director, brings extensive experience in intellectual property management from companies such as Takeda Pharmaceutical and Nippon Shinyaku. Suzuki Kaoru, a new member of the audit committee, previously served as a senior advisor at Roche Partnering and holds significant experience in business development within the pharmaceutical industry. Terada Katsumoto, another new audit committee member, has a strong background in accounting and auditing, having worked with Touche Tomatsu and established his own certified public accountant firm in July 2025.
AI-translated content. 🟢 Confidence: High See terms • Original filing